The overall clinical impression was that 2 of the 8 patients showed marked clinical improvement, 4 showed minimal to moderate improvement, and 2 showed no change. Improvement was mainly in the area of social functioning. Reports of delusions and hallucinations decreased. No extrapyramidal or other side effects were noted. After discontinuation DTγE, 6 of 8 patients showed deterioration. Considerably greater improvement was noted in these patients during the neuroleptic treatment period which followed DTγE. Platelet MAO activity decreased in 6 of the 8 patients during DTγE treatent. No change in serum prolactin levels was observed for up to 4 hours after injection of 1 mg DTγE.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Jan 1 1982|
ASJC Scopus subject areas
- Psychiatry and Mental health
- Pharmacology (medical)